G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling

Leukemia

Volumn 28, Issue 9, 2014, Pages 1851-1860

  Schuettpelz, L G ^a   Borgerding, J N ^a   Christopher, M J ^a   Gopalan, P K ^b   Romine, M P ^a   Herman, A C ^a   Woloszynek, J R ^a   Greenbaum, A M ^a   Link, D C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; MYELOID DIFFERENTIATION FACTOR 88; POLYMYXIN B; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 13; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL EXPANSION; CELL FUNCTION; CHIMERA; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; INTESTINE FLORA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHORT COURSE THERAPY; SIGNAL TRANSDUCTION; SPLEEN; UPREGULATION;

ANIMALS; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; INTESTINES; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84908288477     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.68     Document Type: Article

References (50)

1. Baldridge MT, King KY, Goodell MA. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol. 2011; 32: 57-65
2. King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol. 2011; 11: 685-692
3. Boiko JR, Borghesi L. Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine. 2012; 57: 1-8
4. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med. 2009; 15: 696-700
5. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA., et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 2009; 458: 904-908
6. King KY, Baldridge MT, Weksberg DC, Chambers SM, Lukov GL, Wu S., et al. Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling. Blood. 2011; 118: 1525-1533
7. Zhao X, Ren G, Liang L, Ai PZ, Zheng B, Tischfield JA., et al. Brief report: interferon-gamma induces expansion of Lin(-)Sca-1(+)C-Kit(+) Cells. Stem Cells. 2010; 28: 122-126
8. Esplin BL, Shimazu T, Welner RS, Garrett KP, Nie L, Zhang Q., et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol. 2011; 186: 5367-5375
9. Gross-Weege W, Dumon K, Dahmen A, Schneider EM, Roher HD. Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients. Infection. 1997; 25: 213-216
10. Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine. 2008; 42: 277-288
11. McKinstry WJ, Li CL, Rasko JE, Nicola NA, Johnson GR, Metcalf D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood. 1997; 89: 65-71
12. Richards MK, Liu F, Iwasaki H, Akashi K, Link DC. Pivotal role of granulocyte colonystimulating factor in the development of progenitors in the common myeloid pathway. Blood. 2003; 102: 3562-3568
13. de Haan G, Dontje B, Engel C, Loeffler M, Nijhof W. The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. Blood. 1995; 86: 2986-2992
14. Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood. 1996; 88: 89-97
15. Winkler IG, Pettit AR, Raggatt LJ, Jacobsen RN, Forristal CE, Barbier V., et al. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia. 2012; 26: 1594-1601
16. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood. 2005; 106: 3020-3027
17. Christopher MJ, Link DC. Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation. J Bone Miner Res. 2008; 23: 1765-1774
18. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003; 111: 187-196
19. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002; 3: 687-694
20. Harrison DE, Jordan CT, Zhong RK, Astle CM. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol. 1993; 21: 206-219
21. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 1993; 122: 897-902
22. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood. 2000; 96: 4185-4193
23. Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005; 202: 1599-1611
24. Jorgensen HG, Copland M, Allan EK, Jiang X, Eaves A, Eaves C., et al. Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocytecolony stimulating factor in vitro promotes their elimination by imatinib mesylate. Clinical Cancer Res. 2006; 12: 626-633
25. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/granulocyte colonystimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA. 1997; 94: 1908-1913
26. Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008; 135: 1118-1129
27. Boyd CR, Orr SJ, Spence S, Burrows JF, Elliott J, Carroll HP., et al. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol. 2009; 183: 7703-7709
28. Cook DN, Wang S, Wang Y, Howles GP, Whitehead GS, Berman KG., et al. Genetic regulation of endotoxin-induced airway disease. Genomics. 2004; 83: 961-969
29. van Zuylen WJ, Garceau V, Idris A, Schroder K, Irvine KM, Lattin JE., et al. Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis. PLoS One. 2011; 6: e15723
30. Bruckmaier RM. Gene expression of factors related to the immune reaction in response to intramammary Escherichia coli lipopolysaccharide challenge. J Dairy Res. 2005; 8: 131-141
31. Zheng J, Ather JL, Sonstegard TS, Kerr DE. Characterization of the infectionresponsive bovine lactoferrin promoter. Gene. 2005; 353: 107-117
32. Fessler MB, Malcolm KC, Duncan MW, Worthen GS. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-Activated protein kinase. J Biol Chem. 2002; 277: 31291-31302
33. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S., et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity. 2006; 24: 801-812
34. Zhao Y, Ling F, Wang HC, Sun XH. Chronic TLR signaling impairs the long-Term repopulating potential of hematopoietic stem cells of wild type but not id1 deficient mice. PLoS One. 2013; 8: e55552
35. Rodriguez S, Chora A, Goumnerov B, Mumaw C, Goebel WS, Fernandez L., et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood. 2009; 114: 4064-4076
36. Perry SS, Zhao Y, Nie L, Cochrane SW, Huang Z, Sun XH. Id1 but not Id3, directs long-Term repopulating hematopoietic stem-cell maintenance. Blood. 2007; 110: 2351-2360
37. Ichii M, Shimazu T, Welner RS, Garrett KP, Zhang Q, Esplin BL., et al. Functional diversity of stem and progenitor cells with B-lymphopoietic potential. Immunol Rev. 2010; 237: 10-21
38. Velders GA, van Os R, Hagoort H, Verzaal P, Guiot HF, Lindley IJ., et al. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood. 2004; 103: 340-346
39. Grassinger J, Williams B, Olsen GH, Haylock DN, Nilsson SK. Granulocyte colony stimulating factor expands hematopoietic stem cells within the central but not endosteal bone marrow region. Cytokine. 2012; 58: 218-225
40. Bleharski JR, Niazi KR, Sieling PA, Cheng G, Modlin RL. Signaling lymphocytic activation molecule is expressed on CD40 ligand-Activated dendritic cells and directly augments production of inflammatory cytokines. J Immunol. 2001; 167: 3174-3181
41. Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int Immunol. 2004; 16: 799-809
42. Kruse M, Meinl E, Henning G, Kuhnt C, Berchtold S, Berger T., et al. Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. J Immunol. 2001; 167: 1989-1995
43. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999; 94: 2548-2554
44. Tajima F, Sato T, Laver JH, Ogawa M. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood. 2000; 96: 1989-1993
45. Takizawa H, Regoes RR, Boddupalli CS, Bonhoeffer S, Manz MG. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med. 2011; 208: 273-284
46. Megias J, Yanez A, Moriano S, O'Connor JE, Gozalbo D, Gil ML. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages. Stem Cells. 2012; 30: 1486-1495
47. Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013; 13: 321-335
48. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A., et al. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood. 2007; 110: 4584-4587
49. Chang YJ, Huang XJ. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin Transplant. 2011; 25: 13-23
50. Arcese W, De Angelis G, Cerretti R. Granulocyte-mobilized bone marrow. Curr Opin Hematol. 2012; 19: 448-453